79 related articles for article (PubMed ID: 22344729)
21. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
Tarhan OR; Barut I; Sezik M
J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
[TBL] [Abstract][Full Text] [Related]
22. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
Hutchins FL
J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
[TBL] [Abstract][Full Text] [Related]
23. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.
De Falco M; Staibano S; Mascolo M; Mignogna C; Improda L; Ciociola F; Carbone IF; Di Lieto A
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):44-7. PubMed ID: 19297072
[TBL] [Abstract][Full Text] [Related]
24. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
25. Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: effects of leuprorelin acetate depot on coagulatory and fibrinolytic activities.
Winkler U; Bühler K; Koslowski S; Oberhoff C; Schindler AE
Clin Ther; 1992; 14 Suppl A():114-20. PubMed ID: 1606591
[TBL] [Abstract][Full Text] [Related]
26. Prevention of adhesion formation/reformation with the Gore-Tex Surgical Membrane.
March CM; Boyers S; Franklin R; Haney AF; Hurst B; Lotze E; Rock JA; Rowe G; Schalaff W
Prog Clin Biol Res; 1993; 381():253-9. PubMed ID: 8316567
[TBL] [Abstract][Full Text] [Related]
27. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
Kishk EA; Mohammed Ali MH
Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
[TBL] [Abstract][Full Text] [Related]
28. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
[TBL] [Abstract][Full Text] [Related]
29. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.
Meirow D; Rabinovici J; Katz D; Or R; Shufaro Y; Ben-Yehuda D
Cancer; 2006 Oct; 107(7):1634-41. PubMed ID: 16944540
[TBL] [Abstract][Full Text] [Related]
30. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation.
Sharpe-Timms KL; Zimmer RL; Jolliff WJ; Wright JA; Nothnick WB; Curry TE
Fertil Steril; 1998 May; 69(5):916-23. PubMed ID: 9591503
[TBL] [Abstract][Full Text] [Related]
31. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
32. [Fibroma: surgical myomectomy or embolization or GnRH analogs? Intramural and sub-serous fibroma: start with medical treatment!].
Cohen J
Gynecol Obstet Fertil; 2001 Jan; 29(1):64-6. PubMed ID: 11217196
[No Abstract] [Full Text] [Related]
33. A randomized, prospective, controlled, multicenter clinical trial of a sprayable, site-specific adhesion barrier system in patients undergoing myomectomy.
Mettler L; Audebert A; Lehmann-Willenbrock E; Schive-Peterhansl K; Jacobs VR
Fertil Steril; 2004 Aug; 82(2):398-404. PubMed ID: 15302290
[TBL] [Abstract][Full Text] [Related]
34. Short term effects of GnRH agonists on plasma fibrinolytic balance in patients with advanced prostate cancer.
Agirbasli M; Baykan OA; Tekin A; Sengor F; Cincin AA; Demir M; Vaughan DE
J Thromb Thrombolysis; 2009 Feb; 27(2):172-4. PubMed ID: 18183354
[TBL] [Abstract][Full Text] [Related]
35. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
36. Pregnancies following treatment by GnRH-a (Decapeptyl) and myomectomy in infertile women with uterine leiomyomata.
Abramovici H; Dirnfeld M; Auslander R; Bornstein J; Blumenfeld Z; Sorokin Y
Int J Fertil Menopausal Stud; 1994; 39(3):150-5. PubMed ID: 7920751
[TBL] [Abstract][Full Text] [Related]
37. The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist.
Rein MS; Friedman AJ; Pandian MR; Heffner LJ
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):388-94. PubMed ID: 2116610
[TBL] [Abstract][Full Text] [Related]
38. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
39. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
40. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
Lai HS; Chen Y; Chang KJ; Chen WJ
J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
